FindTrial
Sign In

Validation of DNA methylation biomarkers for cervical cancer detection

Validation of DNA methylation biomarkers for cervical cancer detection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-14005446
Enrollment
Unknown
Registered
2013-06-27
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

Gold Standard:
Index test:

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
43 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Women; 2. Over 20 years old and has sex experience; 3. Agree and Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Had therapy for cervical lesions; 2. Had cancers related to Reproductive Tract (Cervical, Vaginal cancers, Vulvar cancer and Endometrial cancer) Hysterectomy; 3. Received the cervical vaccination; 4. Pregnancy.

Design outcomes

Primary

MeasureTime frame
positive methylation gene results;HPV high rist positive;histology;—

Countries

China

Contacts

Public ContactHonghao Zhou
hhzhou2003@163.com+86-731-84805379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026